Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Cohen

Showing results (571-580 of 676) with videos related to

Pageof 68
Sort By:
American Journal of Ophthalmology|September 8, 2009
Unilateral retinal pigment epithelium dysgenesisSalomon Y Cohen, Anne E Fung, Ramin Tadayoni, et al.
Japanese Journal of Ophthalmology|November 23, 2014
Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumabSalomon Y Cohen, Sylvia Nghiem-Buffet, Typhaine Grenet, et al.
Cancer Biotherapy|January 1, 1995
Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effectsA Adler, J Schachter, Y Barenholz, et al.
Human Genetics|March 12, 2004
SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndromeMaren Runte, Peter M Kroisel, Gabriele Gillessen-Kaesbach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 23, 2013
Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010Salomon Y Cohen, Lise Dubois, Sandrine Ayrault, et al.
Journal of Ophthalmology|June 1, 2018
Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life SettingAnne-Laurence Best, Franck Fajnkuchen, Sylvia Nghiem-Buffet, et al.
Neuromuscular Disorders : NMD|September 11, 2007
Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin geneE Leshinsky-Silver, Z Argov, L Rozenboim, et al.
Retina (Philadelphia, Pa.)|August 13, 2015
PERIPAPILLARY RETINAL PIGMENT EPITHELIUM CHANGES IN AGE-RELATED MACULAR DEGENERATIONSalomon Y Cohen, Lise Dubois, Typhaine Grenet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
Cooperation and competition among frontal eye field neurons during visual target selectionJeremiah Y Cohen, Erin A Crowder, Richard P Heitz, et al.
Retina (Philadelphia, Pa.)|July 6, 2016
RETICULAR PSEUDODRUSEN ARE NOT A PREDICTIVE FACTOR FOR THE 1-YEAR RESPONSE TO INTRAVITREAL RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONSylvia Nghiem-Buffet, Audrey Giocanti-Auregan, Camille Jung, et al.
Pageof 68

Showing results (571-580 of 676) with videos related to

Sort By:
Pageof 68
American Journal of Ophthalmology|September 8, 2009
Unilateral retinal pigment epithelium dysgenesisSalomon Y Cohen, Anne E Fung, Ramin Tadayoni, et al.
Japanese Journal of Ophthalmology|November 23, 2014
Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumabSalomon Y Cohen, Sylvia Nghiem-Buffet, Typhaine Grenet, et al.
Cancer Biotherapy|January 1, 1995
Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effectsA Adler, J Schachter, Y Barenholz, et al.
Human Genetics|March 12, 2004
SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndromeMaren Runte, Peter M Kroisel, Gabriele Gillessen-Kaesbach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 23, 2013
Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010Salomon Y Cohen, Lise Dubois, Sandrine Ayrault, et al.
Journal of Ophthalmology|June 1, 2018
Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life SettingAnne-Laurence Best, Franck Fajnkuchen, Sylvia Nghiem-Buffet, et al.
Neuromuscular Disorders : NMD|September 11, 2007
Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin geneE Leshinsky-Silver, Z Argov, L Rozenboim, et al.
Retina (Philadelphia, Pa.)|August 13, 2015
PERIPAPILLARY RETINAL PIGMENT EPITHELIUM CHANGES IN AGE-RELATED MACULAR DEGENERATIONSalomon Y Cohen, Lise Dubois, Typhaine Grenet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 6, 2010
Cooperation and competition among frontal eye field neurons during visual target selectionJeremiah Y Cohen, Erin A Crowder, Richard P Heitz, et al.
Retina (Philadelphia, Pa.)|July 6, 2016
RETICULAR PSEUDODRUSEN ARE NOT A PREDICTIVE FACTOR FOR THE 1-YEAR RESPONSE TO INTRAVITREAL RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONSylvia Nghiem-Buffet, Audrey Giocanti-Auregan, Camille Jung, et al.
Pageof 68